2.88
price down icon2.04%   -0.06
after-market Dopo l'orario di chiusura: 2.88
loading
Precedente Chiudi:
$2.94
Aprire:
$2.86
Volume 24 ore:
1,287
Relative Volume:
0.00
Capitalizzazione di mercato:
$7.08M
Reddito:
$453.80K
Utile/perdita netta:
$-1.03M
Rapporto P/E:
-4.0089
EPS:
-0.7184
Flusso di cassa netto:
-
1 W Prestazione:
-0.35%
1M Prestazione:
+22.03%
6M Prestazione:
-15.29%
1 anno Prestazione:
-89.71%
Intervallo 1D:
Value
$2.79
$2.88
Intervallo di 1 settimana:
Value
$2.70
$2.94
Portata 52W:
Value
$2.0101
$41.12

X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Company Profile

Name
Nome
X T L Biopharmaceuticals Ltd Adr
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
2
Name
Cinguettio
@xtlbio
Name
Prossima data di guadagno
2026-04-29
Name
Ultimi documenti SEC
Name
XTLB's Discussions on Twitter

Compare XTLB vs VRTX, REGN, ARGX, RVMD, ALNY

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
XTLB icon
XTLB
X T L Biopharmaceuticals Ltd Adr
2.88 7.22M 453.80K -1.03M 0 -0.7184
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
479.00 121.16B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
667.17 68.78B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
888.82 57.44B 4.16B 1.29B 734.26M 19.58
RVMD icon
RVMD
Revolution Medicines Inc
188.07 40.23B 742.00K -1.37B -1.07B -7.0731
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
278.40 36.28B 4.29B 577.22M 641.34M 4.2086

X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2015-05-08 Iniziato H.C. Wainwright Buy

X T L Biopharmaceuticals Ltd Adr Borsa (XTLB) Ultime notizie

pulisher
Jul 25, 2026

XTL Biopharmaceuticals Ltd. Sponsored ADR Revenue Breakdown – FWB:HHB0 - TradingView

Jul 25, 2026
pulisher
Jul 22, 2026

XTL Biopharmaceuticals Regains Nasdaq Compliance and Enters One-Year Monitoring Period - The Globe and Mail

Jul 22, 2026
pulisher
Jul 21, 2026

XTLB Stock Price, Quote & Chart - ChartMill

Jul 21, 2026
pulisher
Jul 12, 2026

Enterprise value to EBITDA forward of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView

Jul 12, 2026
pulisher
Jun 30, 2026

XTL Biopharmaceuticals Completes Psyga Bio Acquisition, Refocuses on Psychedelic Medicine - TipRanks

Jun 30, 2026
pulisher
Jun 29, 2026

XTL Biopharmaceuticals Shareholders Approve Psyga Bio Acquisition and Major Capital Increase - TipRanks

Jun 29, 2026
pulisher
Jun 29, 2026

Wondering what's happening in today's after-hours session? - ChartMill

Jun 29, 2026
pulisher
Jun 29, 2026

XTL Biopharmaceuticals Adjourns Extraordinary Shareholder Meeting to June 29, 2026 - TipRanks

Jun 29, 2026
pulisher
May 29, 2026

XTL Biopharmaceuticals (XTLB) Stock Price, News & Analysis $XTLB - MarketBeat

May 29, 2026
pulisher
May 26, 2026

XTLB - Finviz

May 26, 2026
pulisher
May 22, 2026

XTL Biopharmaceuticals Faces Added Nasdaq Delisting Risk Over Late 2025 Annual Report - TipRanks

May 22, 2026
pulisher
May 22, 2026

XTL Biopharmaceuticals faces additional Nasdaq delisting risk - Investing.com

May 22, 2026
pulisher
May 20, 2026

Eastern International Ltd. expands board, appoints two new directors - Investing.com

May 20, 2026
pulisher
May 16, 2026

XTL Biopharmaceuticals Calls June 22, 2026 Meeting to Approve Psyga Bio Acquisition and Capital Raise - The Globe and Mail

May 16, 2026
pulisher
May 07, 2026

XTL Biopharmaceuticals Wins Conditional Nasdaq Listing Reprieve Tied to Psyga Bio Deal - TipRanks

May 07, 2026
pulisher
Apr 30, 2026

XTL Biopharmaceuticals Delays 20-F Amid Subsidiary Liquidation - TipRanks

Apr 30, 2026
pulisher
Apr 29, 2026

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.57% - Investing.com

Apr 29, 2026
pulisher
Apr 29, 2026

XTL Biopharmaceuticals to Acquire PsygaBio in All-Stock Deal to Expand Psychedelic Drug Pipeline - TipRanks

Apr 29, 2026
pulisher
Apr 28, 2026

Double BottomStock ScreenerCharts - Finviz

Apr 28, 2026
pulisher
Apr 02, 2026

Top GainersStock ScreenerSnapshot - Finviz

Apr 02, 2026
pulisher
Apr 01, 2026

XTL Biopharmaceuticals Ltd ADR Each REPR 40 share price | XTLB - Hargreaves Lansdown

Apr 01, 2026
pulisher
Apr 01, 2026

Debt to assets ratio of XTL Biopharmaceuticals Ltd. Sponsored ADR – GETTEX:HHB0 - TradingView

Apr 01, 2026
pulisher
Apr 01, 2026

Total assets of XTL Biopharmaceuticals Ltd. Sponsored ADR – SWB:HHB0 - TradingView

Apr 01, 2026
pulisher
Apr 01, 2026

Return on invested capital % of XTL Biopharmaceuticals Ltd. Sponsored ADR – SWB:HHB0 - TradingView

Apr 01, 2026
pulisher
Apr 01, 2026

Free cash flow per share of XTL Biopharmaceuticals Ltd. Sponsored ADR – GETTEX:HHB0 - TradingView

Apr 01, 2026
pulisher
Apr 01, 2026

Tangible book value per share of XTL Biopharmaceuticals Ltd. Sponsored ADR – SWB:HHB0 - TradingView

Apr 01, 2026
pulisher
Apr 01, 2026

XTL Biopharmaceuticals Ltd. Sponsored ADR Trade Ideas — SWB:HHB0 - TradingView

Apr 01, 2026
pulisher
Mar 27, 2026

Diluted earnings per share (diluted EPS) of XTL Biopharmaceuticals Ltd. Sponsored ADR – LS:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

XTL Biopharmaceuticals Ltd. Sponsored ADR Cash Flow – LSX:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

Average basic shares outstanding of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

Total operating expenses of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView — Track All Markets

Mar 27, 2026
pulisher
Mar 27, 2026

EBITDA margin % of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

Diluted earnings per share (diluted EPS) of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

EBITDA margin % of XTL Biopharmaceuticals Ltd. Sponsored ADR – LS:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

XTL Biopharmaceuticals Ltd. Sponsored ADR Statistics – LSX:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

Return on assets % of XTL Biopharmaceuticals Ltd. Sponsored ADR – LS:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

Basic earnings per share (basic EPS) of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView — Track All Markets

Mar 27, 2026
pulisher
Mar 27, 2026

XTL Biopharmaceuticals Ltd. Sponsored ADR Statistics – LS:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

Basic earnings per share (basic EPS) of XTL Biopharmaceuticals Ltd. Sponsored ADR – LS:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 26, 2026

Price to cash flow ratio of XTL Biopharmaceuticals Ltd. Sponsored ADR – GETTEX:A41X7J - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Revenue per share of XTL Biopharmaceuticals Ltd. Sponsored ADR – GETTEX:A41X7J - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

XTL Biopharmaceuticals Ltd. Sponsored ADR Statistics – GETTEX:A41X7J - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

XTL Biopharmaceuticals Ltd. Sponsored ADR Balance Sheet – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Diluted earnings per share (diluted EPS) of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Total operating expenses of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Gross margin % of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Long term debt to total equity ratio of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Price to sales ratio of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Operating cash flow per share of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Return on invested capital % of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Return on assets % of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026

X T L Biopharmaceuticals Ltd Adr Azioni (XTLB) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$91.09
price up icon 1.97%
$118.87
price up icon 1.02%
$34.72
price down icon 0.83%
$58.73
price down icon 0.17%
ONC ONC
$325.90
price up icon 0.00%
$278.40
price up icon 2.44%
Capitalizzazione:     |  Volume (24 ore):